InvestorsHub Logo
Followers 46
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

Re: MikePhillips post# 393977

Friday, 08/06/2021 10:22:08 AM

Friday, August 06, 2021 10:22:08 AM

Post# of 694167
Oh, he's popped up a few times over the years, always being critical of autologous DC vaccines. He runs a lab working on a different approach, namely adoptive cell transfer (ACT) targeting specific tumor mutations.
I'm sure others can recall his prior disparaging criticisms.
Immunotherapy is a field with much professional competition. And most researchers like to think that their investigational therapy is the one with the magic bullet, so are prone to making negative comparisons about others.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News